We are live on
!
Find out more
IVMX
Institutional Venture Management XIII Portfolio holdings
AUM
$54.2M
1-Year Est. Return
12.62%
This Fund
S&P 500
This Quarter
Est. Return
-35.24%
1 Year Est. Return
-12.62%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$178M
AUM Growth
-$213M
(-55%)
Cap. Flow
-$97.6M
Cap. Flow
% of AUM
-54.78%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LegalZoom.com
LZ
|
+$57M |
| 2 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
+$40.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 53.22% |
| 2 | Consumer Discretionary | 27.85% |
| 3 | Consumer Staples | 17.04% |
| 4 | Real Estate | 1.88% |
| 5 | Technology | 0% |
Similar funds
MA
MU
SCM
BSM
BSI
BNAGPJ
SRG
SIM
Institutional Venture Management XIII's Q2 2022 Portfolio in Review
As of Q2 2022, Institutional Venture Management XIII held 5 positions worth $178M, down 55% from $392M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Institutional Venture Management XIII withdrew a net $97.6M in Q2 2022, closing 1 position and reducing 1 holding. Its most notable exit was HashiCorp, Inc. Class A Common Stock, an estimated $40.6M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 53% of assets, up from 47% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
- Institutional Venture Management XIII's biggest Q2 2022 reduction was LegalZoom.com, cutting an estimated $57M.
- Institutional Venture Management XIII fully exited HashiCorp, Inc. Class A Common Stock in Q2 2022, selling an estimated $40.6M.
- Institutional Venture Management XIII's ten largest holdings make up 100% of its $178M portfolio in Q2 2022.
- Institutional Venture Management XIII opened 0 new positions and closed 1 in Q2 2022.
- Institutional Venture Management XIII's portfolio value fell 55% quarter-over-quarter to $178M.
Based on Institutional Venture Management XIII's 13F filing for Q2 2022, filed 15 Aug 2022.